More on ROP
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $355.90 |
|
|||
| Open | $358.84 | ||||
| 52 Wk High | $195.93 | ||||
| 52 Wk Low | $155.79 | ||||
| Day High | $363.39 | ||||
| Day Low | $358.20 | ||||
| P/E | 67.15 | ||||
| EPS | $5.37 | ||||
| Volume | 782,871 | ||||
- BMO Capital Starts Roper Industries (ROP) at Market Perform
- BMO Capital Starts Roper Industries (ROP) at Market Perform
- DAT: Dry van spot rates top contract for first time since February 2022; flatbed rates hit record high
- Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC
- Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
- Form S-8 ROPER TECHNOLOGIES INC
- Roper Technologies schedules second quarter 2026 financial results conference call
- FDA grants priority review to Genentech's Enspryng for thyroid eye disease
- FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
- U.S. Bank and DAT: Truck freight rates accelerate
Entities mentioned with ROP
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- Third Point LLC | View Related Stories »
- Show More...
